Homozygote mice are lethal between embryonic day 10.5 & 11.5. Heterozygous PI3K-C2a KI mice were viable and fertile, with no significant histopathological findings. However, male heterozygous mice showed early onset leptin resistance, with a defect in leptin signalling in the hypothalamus,correlating with a mild, age-dependent obesity, insulin resistance and glucose intolerance. Insulin signalling was unaffected in insulin target tissues of PI3K-C2a KI mice, in contrast to previous reports in which downregulation of PI3K-C2a in cell lines was shown to dampen insulin signalling. Interestingly, no metabolic phenotypes were detected in female PI3K-C2a KI mice at any age.
Genetic background:
The genomic DNA encoding the ATP-binding DFG motif in the gene encoding PI3K-C2a (Pik3c2a) is mutated to encode the AFG sequence, resulting in the production of a kinase-dead PI3K-C2a protein.
Production details:
The genomic DNA encoding the ATP-binding DFG motif in the gene encoding PI3K-C2Îą (Pik3c2a) is mutated to encode the AFG sequence, resulting in the production of a kinase-dead PI3K-C2Îą protein.
Additional notes:
Homozygote mice are lethal between embryonic day 10.5 & 11.5. Heterozygous PI3K-C2Îą KI mice were viable and fertile, with no significant histopathological findings. However, male heterozygous mice showed early onset leptin resistance, with a defect in leptin signalling in the hypothalamus,correlating with a mild, age-dependent obesity, insulin resistance and glucose intolerance. Insulin signalling was unaffected in insulin target tissues of PI3K-C2Îą KI mice, in contrast to previous reports in which downregulation of PI3K-C2Îą in cell lines was shown to dampen insulin signalling. Interestingly, no metabolic phenotypes were detected in female PI3K-C2Îą KI mice at any age.
Shipping conditions:
Embryo/Spermatoza- Dry Ice
References:
Alliouachene et al. 2016. Diabetologia. 59(7):1503-1512. PMID: 27138914.
Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.